There has been interest in the use of immune checkpoint inhibitors (ICI) in HGSC, as the levels of tumor infiltrating lymphocytes (TILs) and specific TIL subsets have been significantly correlated with survival [10]. Unfortunately, HGSC response to ICI has, thus far, been mostly ineffective ...